FDA Inspection 646711 — Reckitt Benckiser, Inc.

Reckitt Benckiser, Inc. — FEI 1640689

The FDA completed an inspection of Reckitt Benckiser, Inc. on February 10, 2010 in Fort Worth, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 10, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fort Worth, TX (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
220521 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
358521 CFR 211.110(a)Control procedures to monitor and validate performance
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
890621 CFR 314.81(b)(1)(i)Mix-up